PARADIGM GENETICS INC
10-Q, EX-27.2, 2000-11-03
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: PARADIGM GENETICS INC, 10-Q, EX-27.1, 2000-11-03
Next: UNIVERSAL COMPRESSION INC, 10-K405/A, 2000-11-03



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
*_______________________________________________ AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                       <C>
<PERIOD-TYPE>                   9-MOS                     9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000               DEC-31-1999
<PERIOD-START>                             JAN-01-2000               JAN-01-1999
<PERIOD-END>                               SEP-30-2000               SEP-30-1999
<CASH>                                       4,183,729                         0
<SECURITIES>                                45,570,494                         0
<RECEIVABLES>                                  899,335                         0
<ALLOWANCES>                                         0                         0
<INVENTORY>                                          0                         0
<CURRENT-ASSETS>                            52,081,234                         0
<PP&E>                                      23,037,569                         0
<DEPRECIATION>                               3,937,335                         0
<TOTAL-ASSETS>                              76,740,575                         0
<CURRENT-LIABILITIES>                       22,424,734                         0
<BONDS>                                     11,674,025                         0
                                0                         0
                                          0                         0
<COMMON>                                       257,225                         0
<OTHER-SE>                                  42,384,591                         0
<TOTAL-LIABILITY-AND-EQUITY>                76,740,575                         0
<SALES>                                              0                         0
<TOTAL-REVENUES>                             5,824,916                 1,045,388
<CGS>                                                0                         0
<TOTAL-COSTS>                                        0                         0
<OTHER-EXPENSES>                            20,008,205                 8,326,513
<LOSS-PROVISION>                                     0                         0
<INTEREST-EXPENSE>                           1,049,282                   376,293
<INCOME-PRETAX>                           (13,541,835)               (7,473,342)
<INCOME-TAX>                                         0                         0
<INCOME-CONTINUING>                                  0                         0
<DISCONTINUED>                                       0                         0
<EXTRAORDINARY>                                      0                         0
<CHANGES>                                            0                         0
<NET-INCOME>                              (13,541,835)               (7,473,342)
<EPS-BASIC>                                     (1.60)                    (1.84)
<EPS-DILUTED>                                   (1.60)                    (1.84)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission